An update on the development of HER2-targeted therapies

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:

“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”